LYON, France, Dec. 8, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that its best-in-class Ablatherm®-HIFU device and renewed lithotripsy product line were showcased at two recent international conferences. Eight presentations that support Ablatherm-HIFU’s efficacy for the treatment of localized prostate cancer were featured at the 29th World Congress of Endourology and SWL (WCE), held November 30 – December 3 in Kyoto, Japan. At its booth at the First Montreal Conference on Focal Therapy for Prostate Cancer held December 2 – 3 in Montreal, Canada, EDAP presented the new positioning for robotic Ablatherm-HIFU as the ‘must have’ complement to prostate cancer surgery with its exclusive Canadian distribution partner Maple Leaf HIFU.
